News Column

RAPTOR PHARMACEUTICAL CORP FILES (8-K) Disclosing Entry into a Material Definitive Agreement, Financial Statements and Exhibits

August 21, 2014



Item 1.01 Entry into a Material Definitive Agreement.

As previously disclosed, on July 1, 2014, Raptor Pharmaceutical Corp. (the "Company") entered into an amended and restated loan agreement (the "Amended and Restated Loan Agreement") with HealthCare Royalty Partners II, L.P., as lender (the "Lender"), which revises the terms of the loan agreement, dated as of December 20, 2012, between the Company and the Lender.

A copy of the Amended and Restated Loan Agreement is filed herewith as Exhibit 10.1. Certain information has been omitted from the Amended and Restated Loan Agreement pursuant to a request for confidential treatment filed with the Securities and Exchange Commission.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. Exhibit No. Exhibit Description 10.1* Amended and Restated Loan Agreement, dated as of July 1, 2014, by and among Healthcare Royalty Partners II, L.P., Raptor Pharmaceutical Corp. and the Guarantors party thereto.



* Certain information omitted pursuant to a request for confidential treatment

filed with the SEC.

--------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters